Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
Barbullushi K, Rampi N, Serpenti F, Sciumè M, Fabris S, De Roberto P, Fracchiolla NS. Barbullushi K, et al. Among authors: fabris s. Cancers (Basel). 2022 Jun 17;14(12):2994. doi: 10.3390/cancers14122994. Cancers (Basel). 2022. PMID: 35740657 Free PMC article. Review.
Demystifying the diagnostic criteria of indolent systemic mastocytosis.
Grifoni FI, Sciumè M, Ceparano G, Lavezzari M, Galassi G, Pravettoni V, Eller-Vainicher C, Muratori S, Fabris S, Gianelli U, Giannarelli D, Baldini L. Grifoni FI, et al. Among authors: fabris s. Hematol Oncol. 2022 Feb;40(1):122-124. doi: 10.1002/hon.2920. Epub 2021 Sep 3. Hematol Oncol. 2022. PMID: 34477230 No abstract available.
Target Therapies for Systemic Mastocytosis: An Update.
Sciumè M, De Magistris C, Galli N, Ferretti E, Milesi G, De Roberto P, Fabris S, Grifoni FI. Sciumè M, et al. Among authors: fabris s. Pharmaceuticals (Basel). 2022 Jun 11;15(6):738. doi: 10.3390/ph15060738. Pharmaceuticals (Basel). 2022. PMID: 35745657 Free PMC article. Review.
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine.
Manzoni M, Bosi A, Fabris S, Lionetti M, Salerio S, Migliorini AC, Cavallaro F, Barbullushi K, Rampi N, Montefusco V, Alessio MG, Neri A, Baldini L, Sciumè M, Tagliaferri E, Fracchiolla N, Bolli N. Manzoni M, et al. Among authors: fabris s. Clin Hematol Int. 2022 May 12;4(1-2):52-55. doi: 10.1007/s44228-022-00002-w. eCollection 2022 Jun. Clin Hematol Int. 2022. PMID: 35950209 Free PMC article. No abstract available.
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.
Cortelezzi A, Sciumè M, Liberati AM, Vincenti D, Cuneo A, Reda G, Laurenti L, Zaja F, Marasca R, Chiarenza A, Gritti G, Orsucci L, Storti S, Angelucci E, Cascavilla N, Gobbi M, Mauro FR, Morabito F, Fabris S, Piciocchi A, Vignetti M, Neri A, Rossi D, Giannarelli D, Guarini A, Foà R. Cortelezzi A, et al. Among authors: fabris s. Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13. Leukemia. 2014. PMID: 24220274 Clinical Trial.
220 results